Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

rituximab - Phase 3 | INCY Pipeline | CatalystAlert

rituximab

Phase 3

Incyte Corporation (INCY)

47%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Sep 1

INCY⭐Phase 3Phase 3

Rituximab Phase 3 Results Expected

rituximab • Follicular Lymphoma

Drug Information

Target Indication

Follicular Lymphoma

Clinical Trial

Last updated: 12/4/2025

Developer

INCY

Incyte Corporation

Biotechnology•North America•NASDAQ